Valuation: Biosenta Inc.

Market Cap 1.83M 1.29M 1.13M 1.05M 978K 121M 1.87M 12.57M 4.87M 59.87M 4.83M 4.73M 208M P/E 2024
-1.19x
P/E 2025 -1.59x
Enterprise Value 8.44M 5.93M 5.22M 4.82M 4.5M 559M 8.6M 57.88M 22.42M 276M 22.27M 21.79M 959M EV / Sales 2024
6,101x
EV / Sales 2025 8,809x
Free-Float
87.95%
Yield 2024 *
-
Yield 2025 -
Current month-16.67%
1 month-16.67%
3 months-37.50%
6 months-50.00%
Current year-50.00%
1 week 0.05
Extreme 0.05
0.05
1 month 0.04
Extreme 0.045
0.06
Current year 0.04
Extreme 0.045
0.12
1 year 0.04
Extreme 0.045
0.17
3 years 0.04
Extreme 0.045
0.89
5 years 0.04
Extreme 0.045
0.89
10 years 0
Extreme 0
2.5
Manager TitleAgeSince
Chief Executive Officer - 2019-07-15
Director TitleAgeSince
Chairman 90 2019-07-15
Director/Board Member - 2011-10-04
Chairman 65 2015-02-16
Date Insider Type Main position Quantity % Market Cap.
05-01Option

Chief Executive Officer

-210,000 0.6040%
05-01Option

Director

-807,000 2.3210%
03-02Option

Chief Executive Officer

60,000 0.1741%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-64.29%-83.05% 1.29M
+1.15%+3.91%-7.80%-23.42% 39.96B
-0.38%+3.06%+3.47%+1.17% 23.38B
+0.08%-0.08%-19.89%-38.96% 11.53B
+1.07%+9.49%+23.28%-6.99% 5.42B
+2.97%+5.15%+20.07%-59.37% 3.57B
+1.43%+8.65%+8.27%+33.40% 3.28B
+1.89%-0.18%+11.90%+23.23% 2.85B
-1.38%-4.24%-3.33%+54.21% 1.36B
-1.64%+1.79%+312.60%+757.79% 906M
Average +0.52%+1.88%+28.43%+65.80% 9.23B
Weighted average by Cap. +0.67%+2.13%+0.84%-7.27%

Financials

2024 2025
Net sales 1.38K 969.05 853.15 786.93 736 91.34K 1.4K 9.46K 3.66K 45.06K 3.64K 3.56K 157K 1.21K 851 749.22 691.06 646.33 80.21K 1.23K 8.3K 3.22K 39.57K 3.2K 3.13K 138K
Net income -2.23M -1.57M -1.38M -1.27M -1.19M -148M -2.27M -15.28M -5.92M -72.79M -5.88M -5.75M -253M -2.51M -1.76M -1.55M -1.43M -1.34M -166M -2.55M -17.18M -6.66M -81.88M -6.61M -6.47M -285M
Net Debt 5.54M 3.9M 3.43M 3.16M 2.96M 367M 5.65M 38.02M 14.72M 181M 14.63M 14.31M 630M 6.61M 4.64M 4.09M 3.77M 3.53M 438M 6.73M 45.31M 17.55M 216M 17.43M 17.06M 751M
Logo Biosenta Inc.
Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It develops antimicrobial products that offer environmentally friendly solutions to a global market. Its flagship product, Tri-Filler, represents an antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. Tri-filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-filler can be embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain active for decades and protect the drywall of buildings, objects such as resin furniture, carpet rubber backing and synthetic tufts containing plastic, resin, textiles and others. Its true disinfectant is recognized by Health Canada for use in the fight against COVID-19.
Employees
-
Date Price Change Volume
26-06-19 $0.0500 0.00% 3,000
26-06-16 $0.0500 0.00% 1,000